Philips North America LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$36Mgeneral payments (2019-2025)
$3.4Mresearch payments (2019-2025)
66,957clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $9.4M
2020 $5.4M
2021 $2.1M
2022 $4.3M
2023 $4.7M
2024 $5.6M
2025 $4.1M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Interventional Cardiology $5.7M
Nuclear Cardiology $5.6M
Cardiovascular Disease $5.4M
Clinical Cardiac Electrophysiology $2.6M
Vascular Surgery $2.5M
Diagnostic Radiology $2.2M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Klaus Rentrop New York, NY Nuclear Cardiology $5,633,968.61
George Gellert Prescott, AZ Anesthesiology $582,476.47
Richard Barr Youngstown, OH Diagnostic Radiology $545,363.80
Leslie Scoutt New Haven, CT Diagnostic Radiology $506,604.14
Rogerio Carrillo Hialeah, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $483,107.10
Jasvindar Singh Saint Louis, MO Interventional Cardiology $446,936.35
Rajesh Janardhanan Tucson, AZ Internal Medicine $423,908.78
David Shulkin Morristown, NJ Internal Medicine $377,151.89
Paul Gagne Darien, CT Vascular Surgery $306,829.48
Travis Batts Jbsa Lackland, TX Cardiovascular Disease $292,690.96

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.